NCT07218666
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07218666
Title Zanzalintinib in Men With Aggressive Variant Prostate Cancer (NAPOLEON)
Acronym NAPOLEON
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Deepak Kilari
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.